Wealth Plan Partners, LLC Gilead Sciences, Inc. Transaction History

Wealth Plan Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$71.58 - $87.29 $702,199 - $856,314	9,810 New	9,810 $719 Million
Q2 2023 Jul 31, 2023	SELL	$76.01 - $86.7 $1,140 - $1,300	-15 Reduced 1.23%	1,207 $93 Million
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $94,472 - $107,633	1,222 New	1,222 $101 Million
Q3 2020 Dec 18, 2020	SELL	$62.1 - $78.08 $205,116 - $257,898	-3,303 Closed	0 $0
Q2 2020 Aug 19, 2020	BUY	$72.34 - $84.0 $2,604 - $3,024	36 Added 1.1%	3,303 $225,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $204,612 - $262,078	3,267 New	3,267 $252,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Wealth Plan Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Plan Partners, LLC with notifications on news.